WallStreetZenWallStreetZen

NYSEMKT: APUS
Apimeds Pharmaceuticals Us Inc Stock Ownership - Who owns Apimeds Pharmaceuticals Us?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apimeds Pharmaceuticals Us Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher KimChairman and CMO2025-05-147,730$1.86
$14.38kBuy
Christopher KimChairman and CMO2025-05-1319,770$1.82
$35.98kBuy
Inscobee Inc10% Owner2025-05-1271,090$2.60
$184.83kBuy
Inscobee Inc10% Owner2025-05-1244,041$2.60
$114.51kBuy
Inscobee Inc10% Owner2025-05-1271,090$2.60
$184.83kBuy
Inscobee Inc10% Owner2025-05-1244,041$2.60
$114.51kBuy
Inscobee Inc10% Owner2025-05-12500,000$4.00
$2.00MBuy
Jakap KooDirector2025-05-1228,500$1.99
$56.72kBuy
Inscobee Inc10% Owner2025-05-12182,002$2.60
$473.21kBuy

1 of 1

APUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APUS insiders and whales buy or sell their stock.

APUS Shareholders

What type of owners hold Apimeds Pharmaceuticals Us Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Inscobee Inc44.68%5,619,232$15.00MInsider
Erik C. Emerson5.96%750,000$2.00MInsider
Jakap Koo5.12%643,885$1.72MInsider
Christopher Kim2.21%277,500$740.93kInsider
Citadel Advisors LLC0.11%13,359$35.67kInstitution
Goldman Sachs Group Inc0.10%11,987$32.01kInstitution
Tower Research Capital LLC Trc0.03%3,151$8.41kInstitution
Bank Of America Corp0.00%29$77.43Institution
Jpmorgan Chase Co0.00%5$13.35Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

APUS vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APUS0.23%57.97%Net Buying
CPIX24.62%55.89%Net BuyingNet Buying
QNTM3.05%0.00%
RMTI13.96%86.04%Net SellingNet Selling
SCYX26.46%21.55%Net BuyingNet Buying
View Top Pharmaceutical Stocks

Apimeds Pharmaceuticals Us Stock Ownership FAQ

Who owns Apimeds Pharmaceuticals Us?

Apimeds Pharmaceuticals Us (NYSEMKT: APUS) is owned by 0.23% institutional shareholders, 57.97% Apimeds Pharmaceuticals Us insiders, and 41.80% retail investors. Inscobee Inc is the largest individual Apimeds Pharmaceuticals Us shareholder, owning 5.62M shares representing 44.68% of the company. Inscobee Inc's Apimeds Pharmaceuticals Us shares are currently valued at $15.06M.

If you're new to stock investing, here's how to buy Apimeds Pharmaceuticals Us stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.